Mark C. Willingham - Publications, H-index & Citations

Mark C. Willingham

biotechnology and biological sciences research council (bbsrc)

99H指数

532论文数

4.0W被引数

收录论文 106

发表时间

Regulation of β-catenin by a novel nongenomic action of thyroid hormone β receptor

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27

OAAI

Guigon, Celine J.; Zhao, Li; Lu, Changxue; Willingham, Mark C.; Cheng, Sheue-yann

Dual functions of the steroid hormone receptor coactivator 3 in modulating resistance to thyroid hormone

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27

OAAI

Ying, H; Furuya, F; Willingham, MC; Xu, JM; O'Malley, BW; Cheng, SY

An unliganded thyroid hormone p receptor activates the cyclin D1/cyclin-dependent kinase/retinoblastoma/E2F pathway and induces pituitary tumorigenesis

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27

105

OAAI

Furumoto, H; Ying, H; Chandramouli, GVR; Zhao, L; Walker, RL; Meltzer, PS; Willingham, MC; Cheng, SY

Steroid receptor coactivator-3 as a target for anaplastic thyroid cancer

ENDOCRINE-RELATED CANCER

IF4.6

2020-04-01

OAAI

Lee, Woo Kyung; Kim, Won Gu; Fozzatti, Laura; Park, Sunmi; Zhao, Li; Willingham, Mark; Lonard, David; O'Malley, Bert W.; Cheng, Sheue-yann

Metformin and JQ1 synergistically inhibit obesity-activated thyroid cancer

ENDOCRINE-RELATED CANCER

IF4.6

2018-10-01

OAAI

Park, Sunmi; Willingham, Mark C.; Qi, Jun; Cheng, Sheue-Yann

Defective erythropoiesis caused by mutations of the thyroid hormone receptor α gene

PLOS GENETICS

IF3.7

2017-09-14

OAAI

Park, Sunmi; Han, Cho Rong; Park, Jeong Won; Zhao, Li; Zhu, Xuguang; Willingham, Mark; Bodine, David M.; Cheng, Sheue-yann

Targeting MYC as a Therapeutic Intervention for Anaplastic Thyroid Cancer

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2017-03-28

OAAI

Enomoto, Keisuke; Zhu, Xuguang; Park, Sunmi; Zhao, Li; Zhu, Yuelin J.; Willingham, Mark C.; Qi, Jun; Copland, John A.; Meltzer, Paul .; Cheng, Sheue-yann

SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model

ENDOCRINE-RELATED CANCER

IF4.6

2016-07-01

OAAI

Zhu, Xuguang; Kim, Dong Wook; Zhao, Li; Willingham, Mark C.; Cheng, Sheue-yann

Loss of tyrosine phosphorylation at Y406 abrogates the tumor suppressor functions of the thyroid hormone receptor Y406处酪氨酸磷酸化的丧失消除了甲状腺激素受体的肿瘤抑制功能

MOLECULAR CARCINOGENESIS

IF3.2

2016-06-14

OAAI

Park, Jeong Won; Zhao, Li; Willingham, Mark C.; Cheng, Sheue-yann

Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model

ENDOCRINE-RELATED CANCER

IF4.6

2015-11-09

OAAI

Park, Jeong Won; Han, Cho Rong; Zhao, Li; Willingham, Mark C.; Cheng, Sheue-yann

DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer DMP1β，肿瘤抑制基因DMP1位点的剪接异构体，诱导乳腺癌的增殖和进展

JOURNAL OF PATHOLOGY

IF5.2

2015-02-09

OAAI

Maglic, Dejan; Stovall, Daniel B.; Cline, J. Mark; Fry, Elizabeth A.; Mallakin, Ali; Taneja, Pankaj; Caudell, David L.; Willingham, Mark C.; Sui, Guangchao; Inoue, Kazushi

Testosterone regulates thyroid cancer progression by modifying tumor suppressor genes and tumor immunity

CARCINOGENESIS

IF2.9

2015-01-09

OAAI

Zhang, Lisa J.; Xiong, Yin; Nilubol, Naris; He, Mei; Bommareddi, Swaroop; Zhu, Xuguang; Jia, Li; Xiao, Zhen; Park, Jeong-Won; Xu, Xia; Patel, Dhaval; Willingham, Mark C.; Cheng, Sheue-yann; Kebebew, Electron

Synergistic Signaling of KRAS and Thyroid Hormone Receptor β Mutants Promotes Undifferentiated Thyroid Cancer through MYC Up-Regulation

NEOPLASIA

IF7.7

2014-09-01

OAAI

Zhu, Xuguang; Zhao, Li; Park, Jeong Won; Willingham, Mark C.; Cheng, Sheue-Yann

Inhibition of Tumorigenesis by the Thyroid Hormone Receptor β in Xenograft Models

THYROID

IF6.7

2014-02-01

OAAI

Kim, Won Gu; Zhao, Li; Kim, Dong Wook; Willingham, Mark C.; Cheng, Sheue-yann

Role of DMP1 and its future in lung cancer diagnostics

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2014-01-09

OAAI

Sugiyama, Takayuki; Frazier, Donna P.; Taneja, Pankaj; Morgan, Rachel L.; Willingham, Mark C.; Inoue, Kazushi

A histone deacetylase inhibitor improves hypothyroidism caused by a TR1 mutant

HUMAN MOLECULAR GENETICS

IF3.2

2013-12-30

OAAI

Kim, Dong Wook; Park, Jeong Won; Willingham, Mark C.; Cheng, Sheue-yann

Is Wilms Tumor a Candidate Neoplasia for Treatment with WNT/β-Catenin Pathway Modulators?-A Report from the Renal Tumors Biology-Driven Drug Development Workshop

MOLECULAR CANCER THERAPEUTICS

IF5.5

2013-12-05

OAAI

Perotti, Daniela; Hohenstein, Peter; Bongarzone, Italia; Maschietto, Mariana; Weeks, Mark; Radice, Paolo; Pritchard-Jones, Kathy

Diet-Induced Obesity Increases Tumor Growth and Promotes Anaplastic Change in Thyroid Cancer in a Mouse Model

ENDOCRINOLOGY

IF3.3

2013-08-01

OAAI

Kim, Won Gu; Park, Jeong Won; Willingham, Mark C.; Cheng, Sheue-yann

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis 免疫，增殖和分子亚型在乳腺癌预后中的相互作用

GENOME BIOLOGY

IF9.4

2013-04-29

154

OAAI

Nagalla, Srikanth; Chou, Jeff W.; Willingham, Mark C.; Ruiz, Jimmy; Vaughn, James P.; Dubey, Purnima; Lash, Timothy L.; Hamilton-Dutoit, Stephen J.; Bergh, Jonas; Sotiriou, Christos; Black, Michael A.; Miller, Lance D.

Nuclear receptor corepressor (NCOR1) regulates in vivo actions of a mutated thyroid hormone receptor α

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

IF9.1

2013-04-22

OAAI

Fozzatti, Laura; Kim, Dong Wook; Park, Jeong Won; Willingham, Mark C.; Hollenberg, Anthony N.; Cheng, Sheue-Yann

研究方向